Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.

The first randomized control trial of self-injection in the United States, in which 12-month continuation was an outcome measure, found somewhat higher continuation among women self-injecting compared with women receiving DMPA-SC from a health care provider; however, the difference did not reach statistical significance [9] .

also in 111,027 other papers